Literature DB >> 11735126

Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1.

E S Kang1, C W Park, J H Chung.   

Abstract

Dnmt3b, a DNA methyltransferase, is essential for mammalian development potentially through its transcription repression activity. To comprehend the underlying regulatory mechanism of Dnmt3b, we isolated small ubiquitin-like modifier 1 (SUMO-1) and Ubc9 as Dnmt3b-interacting proteins using yeast two-hybrid screens. Deletion analysis and colocalization experiment demonstrated that Dnmt3b interacts with SUMO-1 and Ubc9 at its N-terminal region. We also confirmed the modification of Dnmt3b by SUMO-1 in vivo. These results suggest that sumoylation may constitute a regulation mechanism of Dnmt3b in vivo. (c)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735126     DOI: 10.1006/bbrc.2001.6057

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

Review 1.  Aberrant DNA methylation in human cancers.

Authors:  Wen Li; Bi-Feng Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

Review 2.  Regulation of mammalian DNA methyltransferases: a route to new mechanisms.

Authors:  Hélène Denis; Matladi N Ndlovu; François Fuks
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

3.  Identification of a novel leukemic-specific splice variant of DNMT3B and its stability.

Authors:  Prachi Singh; Sarvagalla Sailu; Elango Palchamy; Mohane Selvaraj Coumar; Sudhakar Baluchamy
Journal:  Med Oncol       Date:  2017-07-20       Impact factor: 3.064

4.  Increased DNA methyltransferase activity and DNA methylation following Epidermal Growth Factor stimulation in ovarian cancer cells.

Authors:  Sabrina L Samudio-Ruiz; Laurie G Hudson
Journal:  Epigenetics       Date:  2012-03       Impact factor: 4.528

5.  DNMT3b SUMOylation Mediated MMP-2 Upregulation Contribute to Paclitaxel Induced Neuropathic Pain.

Authors:  Han Wang; Yi-Jia Shen; Xiu-Juan Li; Jun Xia; Li Sun; Yehao Xu; Yu Ma; Dai Li; Yuan-Chang Xiong
Journal:  Neurochem Res       Date:  2021-02-06       Impact factor: 3.996

Review 6.  SUMO: a multifaceted modifier of chromatin structure and function.

Authors:  Caelin Cubeñas-Potts; Michael J Matunis
Journal:  Dev Cell       Date:  2013-01-14       Impact factor: 12.270

7.  DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1.

Authors:  Jinah Park; Tae-You Kim; Yeonjoo Jung; Sang-Hyun Song; Sung-Hak Kim; Do-Youn Oh; Seock-Ah Im; Yung-Jue Bang
Journal:  J Mol Med (Berl)       Date:  2008-09-02       Impact factor: 4.599

8.  Lsh participates in DNA methylation and silencing of stem cell genes.

Authors:  Sichuan Xi; Theresa M Geiman; Victorino Briones; Yong Guang Tao; Hong Xu; Kathrin Muegge
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

9.  Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.

Authors:  Yan Ling; Umesh T Sankpal; Andrea K Robertson; James G McNally; Tatiana Karpova; Keith D Robertson
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

10.  Characterization of cytosine methylated regions and 5-cytosine DNA methyltransferase (Ehmeth) in the protozoan parasite Entamoeba histolytica.

Authors:  Ohad Fisher; Rama Siman-Tov; Serge Ankri
Journal:  Nucleic Acids Res       Date:  2004-01-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.